Vladimir Andelkovic

Vladimir Andelkovic

University of Queensland - St Lucia / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5716917
The University of Queensland
person_outline Vladimir Andelkovic's MOST POPULAR ARTICLES
1-) Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trialJM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ...The Lancet Oncology 24 (12), 1399-1410, 20231092023
2-) Targeting BRAF mutations in non-small cell lung cancerCG O’Leary, V Andelkovic, R Ladwa, N Pavlakis, C Zhou, F Hirsch, ...Translational lung cancer research 8 (6), 1119, 2019942019
3-) BMS-986012, an Anti–fucosyl-GM1 monoclonal antibody as monotherapy or in combination with nivolumab in relapsed/refractory SCLC: results from a first-in-human phase 1/2 studyQ Chu, NB Leighl, V Surmont, C van Herpen, A Sibille, B Markman, ...JTO Clinical and Research Reports 3 (11), 100400, 202292022
4-) 1488MO Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT)MM Gounder, RL Jones, R Chugh, M Agulnik, A Singh, BA Van Tine, ...Annals of Oncology 33, S1227-S1228, 2022112022
5-) Foreign body aspiration pneumonia in an intravenous drug userB Bhaskar, V AndelkovicSaudi Journal of Anaesthesia 6 (1), 65-68, 201282012